The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs upgrades roche to preferred pharmaceutical stock with strong growth potential
UBS has named Roche as its preferred Swiss pharmaceutical stock, upgrading its rating to "Buy" and raising the target price from CHF 300 to CHF 338. The firm cites Roche's sustainable growth, driven by strong performances from Vabysmo and Ocrevus, and anticipates significant sales increases from ongoing development projects, including Ocrevus HD and Trontinemab. While Roche's earnings per share growth is projected at 8.1% from 2024 to 2029, slightly below the industry average, UBS remains optimistic about the company's long-term potential and cash flow for acquisitions.
Swiss stock market dips as labor data and tech sector woes weigh down indices
The Swiss stock market experienced a slight decline, with the SMI closing 0.24% lower at 12,593.34 points, marking its first loss after six weeks of gains. Swisscom and Holcim saw gains amid merger rumors, while financial stocks like Julius Baer and Partners Group faced significant losses. The US labor market data influenced investor sentiment, with employment growth slightly below expectations but a drop in the unemployment rate to 4%.
Swiss stock market maintains upward trend amid trade war concerns
The Swiss stock market maintained its upward momentum at midday, with the SMI up 0.44% as concerns over the US-China trade conflict lingered. UBS led gains at +1.9%, while Temenos rose 1.4% after selling its fund management unit. However, Leonteq faced an 8.4% drop following regulatory sanctions.
Swiss stock market opens higher amid improving US and European sentiment
The Swiss stock market opened higher on Thursday, continuing its positive trend from the previous day, buoyed by favorable US data and easing trade tensions. The SMI rose 0.19% to 12,604.86 points, with UBS leading gains at +1.6%, while Nestlé and Roche weighed on the indices. The unemployment rate in Switzerland surpassed 3% in January, reflecting a 20% increase compared to the previous year.
UBS maintains neutral rating for Nestlé amid rising cocoa prices
UBS has maintained a "Neutral" rating for Nestlé, setting a target price of 80 francs. Analyst Guillaume Delmas highlighted concerns regarding the impact of rising cocoa prices on the food group's profitability for the current year.
us tech stocks face pressure as earnings reports and economic data emerge
US tech stocks faced pressure as Alphabet's shares dropped over 8% following disappointing cloud earnings, while AMD fell nearly 10% amid concerns over its AI processor competitiveness against Nvidia. In contrast, Broadcom rose 4% due to its ties with Alphabet. The dollar weakened amid geopolitical uncertainties and mixed economic data, while gold prices reached a record high.
Swiss equities faced a downturn, with the SMI index dropping 0.57% to 12,475.49 points, primarily due to a 7.1% decline in UBS shares amid capital concerns despite positive results. The market remains volatile, influenced by ongoing tariff disputes, particularly with China. Notable losers included Swatch (-3.2%) and Sonova (-3.4%), while Medacta stood out with an 11% gain following strong sales figures.
swiss stock market declines amid escalating trade war tensions
The Swiss stock market is under pressure due to escalating trade tensions following the US tariffs on imports from China, Canada, and Mexico. The Swiss Market Index (SMI) fell 0.61%, with only six of the thirty leading stocks gaining, while UBS saw a significant drop of 5.8% amid profit-taking. Analysts warn of potential broader customs barriers as China retaliates with its own tariffs and a complaint to the WTO.
Swiss stock market declines as UBS and Sonova shares fall sharply
The Swiss stock market faced a downturn, with the SMI index dropping below 12,500, primarily due to a significant decline in UBS shares amid capital concerns. While some companies like Lonza and Medacta saw gains, others, including Swatch and Sonova, struggled as uncertainty from international tariff disputes continued to weigh on investor sentiment.
global markets decline as trump tariffs raise economic concerns
The Swiss stock market closed lower, with the SMI down 0.40% amid global concerns over Donald Trump's new tariffs on key trading partners, which investors fear could harm the economy. While the services sector in Switzerland showed growth, manufacturing faced significant challenges, leading to workforce cuts. Notable stock movements included Julius Bär dropping 12.7% and Lonza rising 2.7%.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.